← SynDRA
SULFACETAMIDE
SynDRA canonical compound SYN0000200 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Mechanism of action | PABA antagonist |
|---|
| Indication | conjunctivitis |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- PABA antagonist
- Candi PMI1 INHIBITOR
- folP INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- MAOA
- NR3C1
- NR1I2
- NPY1R
- MLNR
- MC4R
- MC3R
- KCNH2
- OPRK1
- KAT2A
- IDH1
- HTR3A
- HTR2C
- HTR2B
- HTR2A
- OPRD1
- OPRM1
- HRH3
- SLC6A3
- TSHR
- TDP1
- TBXA2R
- TARDBP
- SMN1
- SLC6A4
- SLC6A2
- PDE3A
- SLC47A1
- SLC29A1
- SAMHD1
- PTGS2
- PGR
- PDE4D
- HTR1A
- HRH2
- ADORA2A
- AGTR1
- CCKAR
- CBX1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Sulfonamide Antibacterial
- Anti-Bacterial Agents
- Anti-Infective Agents
- Anti-Infective Agents, Local
- Anti-Infective Agents, Urinary
ATC classes
- S01A · ANTIINFECTIVES
- D10A · ANTI-ACNE PREPARATIONS FOR TOPICAL USE
Cross-references
Synonyms
- BLEPH-10
- BLEPH-30
- BLEPHAMIDE
- BLEPHAMIDE S.O.P.
- Bleph-10
- Blephamide
- CETAMIDE
- CETAPRED
- FML-S
- GYNE-SULF
- ISOPTO CETAMIDE
- ISOPTO CETAPRED
- acetosulfamin
- acetosulfamine
- formosulfacetamide
- N-Acetylsulfanilamide
- N-Sulfanilylacetamide
- sulfacet
- sulfacetimide
- sulphacetamide
- sulfacetamide sodium
- sulfacetamide sodic hydrate
- Sulfacetamide (triple sulfa)
- Triple sulfa (sulfacetamide)
- Sulfacetamida
- Fml-s
- Sulfacetamidum
- Sulster
- Urosulfon
- NSC-63871
- Sulfacetamide (triple sulfa) component of sultrin
- Sulfacetamide component of gyne-sulf
- Sulfacetamide component of sultrin
- Sulfacetamide component of trysul
- Sulfacetamide component of vagilia
- Acetocid
- Acetosulfamin
- Acetosulfamine
Reported adverse events
- Stevens-Johnson syndrome
- Keratitis
Look up SULFACETAMIDE in the interactive SynDRA portal →